Fol. Biol. 2021, 67, 28-36
https://doi.org/10.14712/fb2021067010028
Serum Cytokine Analysis Reveals Predictors of Progression from Chronic Hepatitis B to Liver Cirrhosis
References
1. , T., Batusic, D., Ringe, B., Ramadori, G. (1997) Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis. J. Hepatol. 26, 1042-1054.
<https://doi.org/10.1016/S0168-8278(97)80113-4>
2. , C. M. (2001) Chronic hepatitis B prevention and treatment guidelines. Chin. J. Infect. Dis. 19, 56-62.
3. , F. (2004) Cancer and the chemokine network. Nat. Rev. Cancer 4, 540-550.
<https://doi.org/10.1038/nrc1388>
4. , J., Brochard, C., Bertrais, S., Michalak, S., Gallois, Y., Fouchard‐Hubert, I., Oberti, F., Rousselet, M. C., Calès, P. (2014) Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C. Aliment. Pharmacol. Ther. 40, 178-188.
<https://doi.org/10.1111/apt.12813>
5. Breiman, L., Friedman, J., Stone, C. J., Olshen, R. A. (1984) Classification and Regression Trees. Chapman and Hall/ CRC Press.
6. , A. W., Metcalf, D. (1980) The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56, 947-958.
<https://doi.org/10.1182/blood.V56.6.947.947>
7. , P., Boursier, J., Oberti, F., Bardou, D., Zarski, J. P., de Lédinghen, V. (2015) Cirrhosis diagnosis and liver fibrosis staging: transient elastometry versus cirrhosis blood test. J. Clin. Gastroenterol. 49, 512-519.
<https://doi.org/10.1097/MCG.0000000000000138>
8. , F., Guerriero, E., Colonna, G., Maio, P., Mangia, A., Marfella, R., Paolisso, G., Izzo, F., Potenza, N., Tomeo, L., Costantini, S. (2015) The cytokinome profile in patients with hepatocellular carcinoma and type 2 diabetes. PLoS One 10, e0134594.
<https://doi.org/10.1371/journal.pone.0134594>
9. , Y., Zhiyong, J., Deying, T. (2003) Clinical significance of granulocyte-macrophage colony-stimulating factor in chronic hepatitis B. Chin. J. Integr. Tradit. West. Med. Liver Dis. 13, 105-107.
10. , V., Martins, C., Novo, C., de Sousa, B., Lopes, Â., Borrego, M., Matos, O. (2013) Dynamics of cytokines and immunoglobulins serum profiles in primary and secondary Cryptosporidium parvum infection: usefulness of Luminex ®; xMAP technology. Exp. Parasitol. 133, 106-113.
<https://doi.org/10.1016/j.exppara.2012.11.003>
11. , S., Capone, F., Guerriero, E., Castello, G. (2009) An approach for understanding the inflammation and cancer relationship. Immunol. Lett. 126, 91-92.
<https://doi.org/10.1016/j.imlet.2009.08.006>
12. , W., Bradshaw, E. M., Uyttenhove, C., Dardalhon, V., Awasthi, A., Imitola, J., Bettelli, E., Oukka, M., Van Snick, J., Khoury, S. J. (2009) IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc. Natl. Acad. Sci. USA 106, 12885-12890.
<https://doi.org/10.1073/pnas.0812530106>
13. , P., Bourlière, M., Pénaranda, G., Deydier, R., Renou, C., Botta-Fridlund, D., Tran, A., Portal, I., Allemand, I., Rosenthal-Allieri, A., Ouzan, D. (2005) Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp. Hepatol. 4, 1-7.
<https://doi.org/10.1186/1476-5926-4-6>
14. Hastie, T., Tibshirani, R., Friedman, J. (2009) The Elements of Statistical Learning. Springer-Verlag, New York.
15. , A., Quinn, H., Glover, C., Henderson, D. C., Allen- Mersh, T. G. (2002) The presence of interleukin-2 receptor α in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation. Cancer Immunol. Immunother. 51, 53-57.
<https://doi.org/10.1007/s00262-002-0320-4>
16. , K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., Tacke, F. (2009) Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50, 261-274.
<https://doi.org/10.1002/hep.22950>
17. , J., Erjefalt, J. S., Andersson, C., Benjamin, E., Jones, C. P., Robichaud, A., Pegorier, S., Brewah, Y., Burwell, T. J., Bjermer, L., Humbles, A. A. (2011) IL-9 governs allergen- induced mast cell numbers in the lung and chronic remodeling of the airways. Am. J. Respir. Crit. Care Med. 183, 865-875.
<https://doi.org/10.1164/rccm.200909-1462OC>
18. , R. A., Metcalf, D., Cuthbertson, R. A., Lyons, I., Stanley, E., Kelso, A., Kannourakis, G., Williamson, D. J., Klintworth, G. K., Gonda, T. J., Dunn, A. R. (1987) Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 51, 675-686.
<https://doi.org/10.1016/0092-8674(87)90136-X>
19. , J. R., Benito-Martínez, S., Calvino, M., Sanz-de- Villalobos, E., Parra-Cid, T. (2008) Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J. Gastroenterol. 14, 7149.
<https://doi.org/10.3748/wjg.14.7149>
20. Lebart, L., Morineau, A., Piron, M. (1995) Statistique Exploratoire Multidimensionelle. Dunod, Paris
21. , X., Bi, S., Yang, W., Wang, L., Cui, G., Cui, F., Zhang, Y., Liu, J., Gong, X., Chen, Y., Wang, Y. (2009) Epidemiological serosurvey of hepatitis B in China - declining HBV prevalence due to hepatitis B vaccination. Vaccine 27, 6550-6557.
<https://doi.org/10.1016/j.vaccine.2009.08.048>
22. , A., Wiener, M. (2002) Classification and regression by randomForest. R News 2, 18-22.
23. , Y. J., Lee, M. H., Yang, H. I., Jen, C. L., You, S. L., Wang, L. Y., Lu, S. N., Liu, J., Chen, C. J. (2013) Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients. PloS One 8, e61448.
<https://doi.org/10.1371/journal.pone.0061448>
24. , F., Zhuang, H. (2009) Management of hepatitis B in China. Chin. Med. J. 122, 3-4.
25. , A., Lukk, M., Kutter, C., Davies, S., Alexander, G., Odom, D. T. (2013) Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker. PloS One 8, e59459.
<https://doi.org/10.1371/journal.pone.0059459>
26. , S. M., Crespo, G., Navasa, M., & Forns, X. (2011) Noninvasive assessment of liver fibrosis. Hepatology 53, 325-335.
<https://doi.org/10.1002/hep.24013>
27. , K., Okudaira, M., Akashio, K. (1972) Mast cells in human liver tissue. Increased mast cell number in relation to the components of connective tissue in the cirrhotic process. Acta Derm. Venereol. 73, 157-165.
28. , A. J., Yoon, S. K., Lencioni, R. (2010) The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 15(Suppl. 4), 14-22.
<https://doi.org/10.1634/theoncologist.2010-S4-14>
29. , P. A., Talwalkar, J. A. (2011) Noninvasive tools to assess hepatic fibrosis: ready for prime time? Gastroenterol. Clin. North. Am. 40, 507-521.
<https://doi.org/10.1016/j.gtc.2011.06.010>
30. , S. G., Flamm, S. L., Gordon, F. D., Chopra, S. (1998) AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 93, 44-48.
<https://doi.org/10.1111/j.1572-0241.1998.044_c.x>
31. , N. L., Hindorff, L. A., Heckbert, S. R., Lemaitre, R. N., Marciante, K. D., Rice, K., Lumley, T., Bis, J. C., Wiggins, K. L., Rosendaal, F. R. (2007) Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA 297, 489-498.
<https://doi.org/10.1001/jama.297.5.489>
32. , N. M., Foureau, D. M., Norton, H. J., Zhou, J., Parsons, J. C., Chalasani, N., Fontana, R. J., Watkins, P. B., Lee, W. M., Reddy, K. R. (2013) Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance. Plos One 8, e81974.
<https://doi.org/10.1371/journal.pone.0081974>
33. , Y. J. (2011) Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J. Gastroenterol. 17, 48-53.
<https://doi.org/10.3748/wjg.v17.i44.4853>
34. , M. J., Fallon, P. G., Matthews, D. J., Smith, P., Jolin, H. E., McKenzie, A. N. (2000) IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13, 573-583.
<https://doi.org/10.1016/S1074-7613(00)00056-X>
35. , K., Burt, A., Wright, M. (2008) Liver fibrosis. Biochem. J. 411, 1-18.
<https://doi.org/10.1042/BJ20071570>
36. , N. S., Kadarmideen, H. N., Reverter, A. (2010) PCIT: an R package for weighted gene co-expression networks based on partial correlation and information theory approaches. Bioinformatics 26, 411-413.
<https://doi.org/10.1093/bioinformatics/btp674>
37. , Z., Ohkawara, Y., Jordana, M., Graham, F., Gauldie, J. (1996) Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J. Clin. Invest. 97, 1102.
<https://doi.org/10.1172/JCI118503>
38. , D., Fu, J., Jin, L., Zhang, H., Zhou, C., Zou, Z., Zhao, J. M., Zhang, B., Shi, M., Ding, X. (2006) Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 177, 739-747.
<https://doi.org/10.4049/jimmunol.177.1.739>
39. , M., Xu, D., Liu, Y., Guo, X., Li, W., Guo, C., Zhang, H., Gao, Y., Mao, Y., Zhao, J. (2015) Combined serum biomarkers in non-invasive diagnosis of non-alcoholic steatohepatitis. PloS One 10, e0131664.
<https://doi.org/10.1371/journal.pone.0131664>
40. , Y. X., Hai, W. B. (1994) Standard of clinic diagnosis, syndrome differentiation and assessing curative effect on hepatocirrhosis. Chin. J. Integr. Tradit. West. Med. 14, 237-238.
